Corixa and GlaxoSmithKline Respond to FDA; Complete Review Letter for BEXXAR.
Business Wire › March 25, 2002
Linked as:
Business Wire › March 25, 2002
Linked as:Extract
Corixa and GlaxoSmithKline Respond to FDA; Complete Review Letter for BEXXAR.
Business Editors & Health/Medical Writers
BIOWIRE2K SEATTLE & PHILADELPHIA--(BW HealthWire)--March 25, 2002 Corixa Corporation (Nasdaq:CRXA) and GlaxoSmithKline (NYSE:GSK), today announced that Corixa ha...See the full content of this document
Sponsored links
ver las páginas en versión mobile | web
ver las páginas en versión mobile | web
© Copyright 2012, vLex. All Rights Reserved.
Contents in vLex United States
Explore vLex
For Professionals
For Partners
Company
Other documents:
Governor Visits Chaffey High | A Dog Named Lucky and His Lucky Owner | local news briefs | Energy-Saving Practices Lower Building s Bills in Okc | Sentencia nº 2130 de Consiglio di Stato, May 12, 2010 | Sentencia nº 5496 de Consiglio di Stato, October 17, 2008 | Sentencia nº 3576 de Consiglio di Stato July 29 2010 | Sentencia nº 2876 de Consiglio di Stato June 22 2010